← Leaderboards
Shelley L Magill
Johns Hopkins University
$657,450
Attributed
$657,450
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $131.5K · FY2005–07$200K$150K$100K$50K$0
'05
'06
'07
Funding mix
By agency
NIH$657,450 · 1
By mechanism
K23$657,450 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Kyle W Cunningham$5,999,195
- Richard E Rothman$4,041,393
- Arlene Manns Butz$9,556,380
- Steve Nicholas Georas$14,862,894
- Peter J Pronovost$14,668,258
Others in their field
Top investigators on “Fluconazole”
- David Bisagaya Meya · Infectious Diseases Institute$9,165,561
- David R Boulware · University Of Minnesota$7,702,341
- P David Rogers · University Of Tennessee Health Sci Ctr$7,445,848
- Theodore C. White · Seattle Biomedical Research Institute$6,476,809
- Radha Rajasingham · University Of Minnesota$6,079,720
- James B. Konopka · State University New York Stony Brook$5,070,340
Research focus
FluconazoleDisease /Disorder Proneness /RiskClinical TrialsCandidiasisPatient Oriented ResearchCandida AlbicansDisease /Disorder Prevention /ControlClinical ResearchIntensive CareHuman Therapy EvaluationMicroorganism Disease ChemotherapyHuman MortalityHuman SubjectHospital Length Of StayDrug ResistanceHuman DataCommunicable Disease TransmissionCessation Of LifeBiometryCandidemiaAzole ResistanceAntimicrobial ResistanceDiagnosisCritical Illness
Grant awards (5)
Prevention of Candidiasis in Critically III Patients$131,490
K23 · FY2007 · AI · contact PI
Prevention of Candidiasis in Critically III Patients$131,490
K23 · FY2006 · AI · contact PI
Prevention of Candidiasis in Critically III Patients$131,490
K23 · FY2005 · AI
Prevention of Candidiasis in Critically III Patients$131,490
K23 · FY2004 · AI
Prevention of Candidiasis in Critically III Patients$131,490
K23 · FY2003 · AI